One Hundred Consecutive Isolated Limb Perfusions With TNF-α and Melphalan in Melanoma Patients With Multiple In-Transit Metastases
Dirk J. Grünhagen(Erasmus MC), Alexander M.M. Eggermont(University Medical Center Utrecht), Albertus N. van Geel, Flávia Brunstein, Wilfried J. Graveland(Erasmus MC Cancer Institute), Johannes H.W. de Wilt(Radboud University Nijmegen)
Cited by 125
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k